RA
ALIM

Royce & Associates’s Alimera Sciences ALIM Stock Holding History

Royce & Associates’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-61,125
Closed -$235K – 1235
2020
Q1 		$235K Buy
61,125
+15,000
+33% +$91.3K ﹤0.01% 908
2019
Q4 		$350K Buy
46,125
+3,333
+8% +$19.9K ﹤0.01% 925
2019
Q3 		$363K Buy
42,792
+5,000
+13% +$45.4K ﹤0.01% 928
2019
Q2 		$505K Sell
37,792
-293
-0.8% -$4.13K ﹤0.01% 906
2019
Q1 		$606K Buy
38,085
+16,806
+79% +$256K 0.01% 906
2018
Q4 		$229K Buy
21,279
+8,000
+60% +$117K ﹤0.01% 974
2018
Q3 		$195K Buy
+13,279
New +$202K ﹤0.01% 1015

Other funds holding ALIM

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royce & Associates's ALIM Position: Q2 2020 in Review

Royce & Associates sold out of Alimera Sciences (ALIM) in Q2 2020, closing a stake of 61,125 shares — an estimated $235K sold.

Royce & Associates first reported a position in ALIM in Q3 2018 and held it in 7 quarters. The position peaked at $606K in Q1 2019. 19 funds tracked by Wall St. Rank hold ALIM as of Q2 2020.

  • Royce & Associates reported no remaining Alimera Sciences position as of Q2 2020 after selling out during the quarter.
  • Royce & Associates sold 61,125 Alimera Sciences shares in Q2 2020, an estimated $235K.
  • Royce & Associates first reported a position in Alimera Sciences in Q3 2018 and held it in 7 quarters.
  • Royce & Associates's Alimera Sciences position peaked at $606K in Q1 2019.
  • 19 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2020.

Based on Royce & Associates's 13F filing for Q2 2020, filed 7 Aug 2020.